189 related articles for article (PubMed ID: 36683090)
21. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
22. Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial.
Moreno ML; Goerigk SA; Bertola L; Suemoto CK; Razza LB; Moffa AH; Veronezi BP; Tort L; Nogueira BS; Gattaz WF; Fraguas R; Padberg F; Lotufo PA; Benseñor IM; Brunoni AR
J Affect Disord; 2020 Feb; 263():344-352. PubMed ID: 31969264
[TBL] [Abstract][Full Text] [Related]
23. Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial.
Johansen A; Armand S; Plavén-Sigray P; Nasser A; Ozenne B; Petersen IN; Keller SH; Madsen J; Beliveau V; Møller K; Vassilieva A; Langley C; Svarer C; Stenbæk DS; Sahakian BJ; Knudsen GM
Mol Psychiatry; 2023 Oct; 28(10):4272-4279. PubMed ID: 37814129
[TBL] [Abstract][Full Text] [Related]
24. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
25. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.
Montejo AL; Deakin JF; Gaillard R; Harmer C; Meyniel F; Jabourian A; Gabriel C; Gruget C; Klinge C; MacFayden C; Milligan H; Mullings E; Goodwin G
J Psychopharmacol; 2015 Oct; 29(10):1119-28. PubMed ID: 26268533
[TBL] [Abstract][Full Text] [Related]
26. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase.
Dell'Osso B; Hadley S; Allen A; Baker B; Chaplin WF; Hollander E
J Clin Psychiatry; 2008 Mar; 69(3):452-6. PubMed ID: 18312057
[TBL] [Abstract][Full Text] [Related]
27. SSRI enhances sensitivity to background outcomes and modulates response rates: A randomized double blind study of instrumental action and depression.
Msetfi RM; Kumar P; Harmer CJ; Murphy RA
Neurobiol Learn Mem; 2016 May; 131():76-82. PubMed ID: 26976091
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Escitalopram on Central Serotonergic and Dopaminergic Systems in Patients with Cervical Dystonia, and Its Relationship with Clinical Treatment Effects: A Double-Blind Placebo-Controlled Trial.
Zoons E; Tijssen MAJ; Dreissen YEM; Smit M; Booij J
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32521736
[No Abstract] [Full Text] [Related]
29. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Ziprasidone Augmentation of Escitalopram for Cognitive Symptoms of Major Depressive Disorder.
Iovieno N; Shelton RC; Petrie SR; Cusin C; Fava M; Papakostas GI
J Clin Psychiatry; 2018; 79(1):. PubMed ID: 28749091
[TBL] [Abstract][Full Text] [Related]
31. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.
Wade A; Michael Lemming O; Bang Hedegaard K
Int Clin Psychopharmacol; 2002 May; 17(3):95-102. PubMed ID: 11981349
[TBL] [Abstract][Full Text] [Related]
32. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
33. Escitalopram treatment for depressive disorder following acute coronary syndrome: a 24-week double-blind, placebo-controlled trial.
Kim JM; Bae KY; Stewart R; Jung BO; Kang HJ; Kim SW; Shin IS; Hong YJ; Kim JH; Shin HY; Kang G; Ahn Y; Kim JK; Jeong MH; Yoon JS
J Clin Psychiatry; 2015 Jan; 76(1):62-8. PubMed ID: 25375836
[TBL] [Abstract][Full Text] [Related]
34. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
Azorin JM; Llorca PM; Despiegel N; Verpillat P
Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
[TBL] [Abstract][Full Text] [Related]
35. Improvement in subjective and objective neurocognitive functions in patients with major depressive disorder: a 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
Jeon HJ; Woo JM; Lee SH; Kim EJ; Chung S; Ha JH; Fava M; Mischoulon D; Kim JH; Heo JY; Yu BH
J Clin Psychopharmacol; 2014 Apr; 34(2):218-25. PubMed ID: 24525660
[TBL] [Abstract][Full Text] [Related]
36. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.
Lu L; Mills JA; Li H; Schroeder HK; Mossman SA; Varney ST; Cecil KM; Huang X; Gong Q; Ramsey LB; DelBello MP; Sweeney JA; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2021 Oct; 60(10):1309-1318. PubMed ID: 33548492
[TBL] [Abstract][Full Text] [Related]
37. Escitalopram: a review of its use in the management of major depressive disorder in adults.
Garnock-Jones KP; McCormack PL
CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
[TBL] [Abstract][Full Text] [Related]
38. SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects.
Paul MA; Gray GW; Love RJ; Lange M
Aviat Space Environ Med; 2007 Jul; 78(7):693-7. PubMed ID: 17679567
[TBL] [Abstract][Full Text] [Related]
39. S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response.
Sarris J; Papakostas GI; Vitolo O; Fava M; Mischoulon D
J Affect Disord; 2014 Aug; 164():76-81. PubMed ID: 24856557
[TBL] [Abstract][Full Text] [Related]
40. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
